Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Jonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Cancer Cell (2016) Vol. 30, Iss. 6, pp. 891-908
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

The SWI/SNF complex in cancer — biology, biomarkers and therapy
Priya Mittal, Charles W.M. Roberts
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 7, pp. 435-448
Open Access | Times Cited: 472
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
Johanna Theruvath, Elena Sotillo, Christopher Mount, et al.
Nature Medicine (2020) Vol. 26, Iss. 5, pp. 712-719
Open Access | Times Cited: 236
Stalled developmental programs at the root of pediatric brain tumors
Selin Jessa, Alexis Blanchet-Cohen, Brian Krug, et al.
Nature Genetics (2019) Vol. 51, Iss. 12, pp. 1702-1713
Open Access | Times Cited: 210
Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
Ben Ho, Pascal D. Johann, Yura Grabovska, et al.
Neuro-Oncology (2019) Vol. 22, Iss. 5, pp. 613-624
Open Access | Times Cited: 178
Molecular pathology of tumors of the central nervous system
Bjarne Winther Kristensen, Loudy P. Priesterbach-Ackley, Jeanette Krogh Petersen, et al.
Annals of Oncology (2019) Vol. 30, Iss. 8, pp. 1265-1278
Open Access | Times Cited: 177
GenPipes: an open-source framework for distributed and scalable genomic analyses
Mathieu Bourgey, Rola Dali, Robert Eveleigh, et al.
GigaScience (2019) Vol. 8, Iss. 6
Open Access | Times Cited: 173
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Yura Grabovska, Alan Mackay, Patricia O’Hare, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 158
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer
Adrian P. Bracken, Gerard L. Brien, C. Peter Verrijzer
Genes & Development (2019) Vol. 33, Iss. 15-16, pp. 936-959
Open Access | Times Cited: 154
Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children’s Oncology Group Trial ACNS0333
Alyssa Reddy, Douglas Strother, Alexander R. Judkins, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 11, pp. 1175-1185
Open Access | Times Cited: 143
Chromatin accessibility profiling methods
Liesbeth Minnoye, Georgi K. Marinov, Thomas Krausgruber, et al.
Nature Reviews Methods Primers (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 135
Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis
Raymond Chen, Charles A. Ishak, Daniel D. De Carvalho
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2707-2725
Open Access | Times Cited: 129
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
Zhiqiang Wang, Zhao-Cong Zhang, Yuyang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
A biobank of patient-derived pediatric brain tumor models
Sebastian Brabetz, Sarah Leary, Susanne Gröbner, et al.
Nature Medicine (2018) Vol. 24, Iss. 11, pp. 1752-1761
Closed Access | Times Cited: 143
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
Amaury Leruste, Jimena Tosello, Rodrigo Nalio Ramos, et al.
Cancer Cell (2019) Vol. 36, Iss. 6, pp. 597-612.e8
Open Access | Times Cited: 132
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours
David Jones, Ana Banito, Thomas G. P. Grünewald, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 420-438
Closed Access | Times Cited: 130
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors
Michael C. Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Neuro-Oncology (2019) Vol. 22, Iss. 7, pp. 1006-1017
Open Access | Times Cited: 104
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
Hye-Jung E. Chun, Pascal D. Johann, Katy Milne, et al.
Cell Reports (2019) Vol. 29, Iss. 8, pp. 2338-2354.e7
Open Access | Times Cited: 92
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
Bryan Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 2, pp. 223-241
Open Access | Times Cited: 90
A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions
Elena Grossi, Ivan Raimondi, Enrique Goñi, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 79
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Alessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.
Cancer Cell (2019) Vol. 35, Iss. 2, pp. 204-220.e9
Open Access | Times Cited: 77
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Patrick Sin‐Chan, Iqra Mumal, Tannu Suwal, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 51-67.e7
Open Access | Times Cited: 76
Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
Lars Custers, Eleonora Khabirova, Tim H. H. Coorens, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
Garrett W. Cooper, Andrew L. Hong
Cancers (2022) Vol. 14, Iss. 15, pp. 3645-3645
Open Access | Times Cited: 43
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 660-677.e7
Open Access | Times Cited: 34
Chromatin remodellers as therapeutic targets
Hayden A. Malone, Charles W.M. Roberts
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 661-681
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top